IPO Synopsis

Syngene International Ltd
Registered Office: Biocon SEZ Biocon Park,Plot No 2 & 3 Bommasandra Inds,Bengaluru-560099, Karnataka
Tel. No: 91-80-68915000/67758781
Fax No: 91-80-28083189
Email: investor@syngeneintl.com; Mayank.Verma@syngeneintl
Website: www.syngeneintl.com
Initial public offer of up to 22,000,000 equity shares of face value of Rs. 10 each ("equity shares") of Syngene International Limited ("company" or "issuer") for cash at a price of Rs. 250 per equity share (including a share premium of Rs. 240 per equity share) ("offer price") through an offer for sale by Biocon Limited (the "selling shareholder") ("offer / offer for sale") aggregating to Rs. 550 crores including a reservation of 2,000,000 equity shares for subscription by Biocon shareholders for cash at a price of Rs. 250 per equity share aggregating up to Rs. 50 crores (the "Biocon shareholders reservation portion"). The offer will constitute 11.0% of the post-offer paid-up equity share capital and the net offer shall constitute 10.0% of the post-offer paid-up equity share capital. Offer Price : Rs. 250 per Equity share of face value of Rs. 10/- each. The offer price is 25 times of the face value. Anchor investor offer price : Rs. 250 per equity share.
Issue Money Payable On
Opens On Closes On Application Allotment
27-Jul-2015 29-Jul-2015 ₹250.00 - 0.00 ₹0.00 - 0.00
Minimum Application for shares in Nos : 60 Further Multiples of :60
(₹ Cr) Lead Managers to the Issue
Project Cost 37.00 Axis Capital Ltd
Project Financed through Current Offer 550.00 Credit Suisse Securities (India) Pvt Ltd
Post Issue Equity Share Capital 200.00 Jefferies India Pvt Ltd
Issue Price 250.00
Projects
Listing fees on Stock Exchanges
Promoted By
Biocon Ltd
Listing At
BSE
NSE
Registrar To The Issue